6FK.F 3.24 (-0.61%)
NO0010748866• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. 6FK.F

Gentian Diagnostics (6FK.F) Competitor Comparison

We are evaluating the key criteria listed to compare Gentian Diagnostics (6FK.F) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 56

Dividend yield

0 / 9

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Linearity 5 years - 6FK.F ranking 0 / 58

These are the competitors of Gentian Diagnostics in the industry Diagnostics & Research ranked by linearity 5 years
1. Co-Diagnostics CODX
100.26
2. CareDx CDNA
36.23
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. DarioHealth DRIO
31.71
5. Anixa Biosciences ANIX
29.33
6. Inotiv NOTV
27.28
7. Syneos Health SYNH
24.79
8. Fulgent Genetics FLGT
19.79
9. Heska HSKA
15.42
10. Charles River Laboratories CRL
15.1
11. Icon ICLR
13.14
12. IQVIA Holdings IQV
10.15
13. Olink Holding OLK
8.53
14. DexCom DXCM
8.38
15. Pacific Biosciences of California PACB
8.08
16. Qiagen QGEN
7.13
17. Aspira Womens Health AWH
5.9
18. Personalis PSNL
5.72
19. IDEXX Laboratories IDXX
5.33
20. Mettler-Toledo MTD
5.01
21. PerkinElmer PKI
4.97
22. Exact Sciences EXAS
4.95
23. Quest Diagnostics DGX
4.95
24. Trinity Biotech TRIB
4.91
25. NeoGenomics NEO
4.78
26. Twist Bioscience TWST
4.51
27. Thermo Fisher Scientific TMO
4.39
28. Agilent Technologies A
4.34
29. Myriad Genetics MYGN
4.23
30. Interpace Biosciences IDXG
4.05
31. Laboratory Corp of America Holdings LH
3.96
32. Danaher DHR
3.94
33. Sera Prognostics SERA
3.81
34. Illumina ILMN
3.73
35. Neogen NEOG
3.68
36. Sotera Health SHC
3.68
37. Waters WAT
3.67
38. Guardant Health GH
3.6
39. Enzo Biochem ENZ
3.59
40. Bioventus BVS
2.96
41. National Research NRC
2.7
42. Precipio PRPO
2.47
43. Psychemedics PMD
2.4
44. Neuronetics STIM
2.28
45. Global Cord Blood CO
2.23
46. MaxCyte MXCT
2.09
47. MDxHealth MDXH
2.02
48. Biodesix BDSX
1.91
49. Prenetics Global PRE
1.79
50. Exagen XGN
1.69
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Medpace Holdings MEDP
0.67
56. Natera NTRA
0.6
57. Lantheus Holdings LNTH
0.43
58. RadNet RDNT
0.39
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.